For example, high expression levels of ERCC1 and BRCA1, which are crucial for DNA repair, negatively affect the efficacy of platinum drugs and are thought to be a major predictor of tumor responses to platinum-based chemotherapy [8,9]. Here, ERCC1 is linked to neoplasm.